期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Aging: A cell source limiting factor in tissue engineering 被引量:4
1
作者 Mohammadhossein Khorraminejad-Shirazi Mohammadreza Dorvash +3 位作者 alireza estedlal Amir Human Hoveidaei Mohsen Mazloomrezaei Pouria Mosaddeghi 《World Journal of Stem Cells》 SCIE 2019年第10期787-802,共16页
Tissue engineering has yet to reach its ideal goal,i.e.creating profitable off-theshelf tissues and organs,designing scaffolds and three-dimensional tissue architectures that can maintain the blood supply,proper bioma... Tissue engineering has yet to reach its ideal goal,i.e.creating profitable off-theshelf tissues and organs,designing scaffolds and three-dimensional tissue architectures that can maintain the blood supply,proper biomaterial selection,and identifying the most efficient cell source for use in cell therapy and tissue engineering.These are still the major challenges in this field.Regarding the identification of the most appropriate cell source,aging as a factor that affects both somatic and stem cells and limits their function and applications is a preventable and,at least to some extents,a reversible phenomenon.Here,we reviewed different stem cell types,namely embryonic stem cells,adult stem cells,induced pluripotent stem cells,and genetically modified stem cells,as well as their sources,i.e.autologous,allogeneic,and xenogeneic sources.Afterward,we approached aging by discussing the functional decline of aged stem cells and different intrinsic and extrinsic factors that are involved in stem cell aging including replicative senescence and Hayflick limit,autophagy,epigenetic changes,miRNAs,mTOR and AMPK pathways,and the role of mitochondria in stem cell senescence.Finally,various interventions for rejuvenation and geroprotection of stem cells are discussed.These interventions can be applied in cell therapy and tissue engineering methods to conquer aging as a limiting factor,both in original cell source and in the in vitro proliferated cells. 展开更多
关键词 AGING SENESCENCE REJUVENATION Geroprotection TISSUE engineering Stem CELL therapy
下载PDF
Conduction system disorders and electro-cardiographic findings in COVID-19 deceased patients in 2021,Shiraz,Iran
2
作者 Mohammad Hossein Nikoo alireza Sadeghi +9 位作者 alireza estedlal Reza Fereidooni Niloofar Dehdari Ebrahimi Amirhossein Maktabi Mahtab Kamgar Fatemeh Mehran Omid Mehdibeygi Haleh Esfandiari Mohammadamir Taherinezhad Tayebi Seyed Taghi Heydari 《World Journal of Cardiology》 2022年第12期617-625,共9页
BACKGROUND Cardiac conduction disorders and electrocardiographic(ECG)changes may occur as a manifestation of coronavirus disease 2019(COVID-19),especially in severe cases.AIM To describe conduction system disorders an... BACKGROUND Cardiac conduction disorders and electrocardiographic(ECG)changes may occur as a manifestation of coronavirus disease 2019(COVID-19),especially in severe cases.AIM To describe conduction system disorders and their association with other electrocardiographic parameters in patients who died of COVID-19.METHODS In this cross-sectional study,electrocardiographic and clinical data of 432 patients who expired from COVID-19 between August 1st,2021,and December 1st,2021,in a tertiary hospital were reviewed.RESULTS Among 432 patients who died from COVID-19,atrioventricular block(AVB)was found in 40(9.3%).Among these 40 patients,28(6.5%)suffered from 1st degree AVB,and 12(2.8%)suffered from complete heart block(CHB).Changes in ST-T wave,compatible with myocardial infarction or localized myocarditis,appeared in 189(59.0%).Findings compatible with myocardial injury,such as fragmented QRS and prolonged QTc,were found in 91 patients(21.1%)and 28 patients(6.5%),respectively.In patients who died of COVID-19,conduction disorder was unrelated to any underlying medical condition.Fragmented QRS,axis deviation,and ST-T changes were significantly related to conduction system disorder in patients who died of COVID-19(P value<0.05).CONCLUSION Conduction system disorders are associated with several other ECG abnormalities,especially those indicative of myocardial ischemia or inflammation.Most patients(73.14%)who died of COVID-19 demonstrated at least one ECG abnormality parameter.Since a COVID-19 patient's ECG gives important information regarding their cardiac health,our findings can help develop a risk stratification method for at-risk COVID-19 patients in future studies. 展开更多
关键词 COVID-19 Conduction system disorder ELECTROCARDIOGRAPHY Atrioventricular block
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部